|
|
Exchange: |
N/A |
Security
Type: |
N/A |
Shares
Out: |
10,950,000 |
Market
Cap: |
N/A |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$ - $ |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile MAIA Biotechnology is a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer. Co.'s primary product candidate, 6-thio-dG or 6-thio-2'-deoxyguanosine (THIO), is a telomere-targeting agent in clinical development to evaluate its activity in non-small cell lung cancer (NSCLC). THIO is being developed as a second- or later line of treatment for NSCLC for patients that have progressed beyond the standard-of-care regimen of existing checkpoint inhibitors. Co.'s pipeline includes THIO-102, which is targeting colorectal cancer and THIO-103, which is targeting basket study.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
119,999 |
301,665 |
612,883 |
1,232,771 |
Total Buy Value |
$179,999 |
$452,499 |
$1,183,625 |
$2,052,650 |
Total People Bought |
2 |
2 |
4 |
5 |
Total Buy Transactions |
3 |
7 |
13 |
20 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2025-04-10 |
2025-01-07 |
2024-07-09 |
2023-07-10 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Smith Stan |
Director |
|
2025-06-03 |
4 |
B |
$1.50 |
$50,000 |
I/I |
33,333 |
1,305,059 |
2.1 |
- |
|
Smith Stan |
Director |
|
2025-05-08 |
4 |
B |
$1.50 |
$99,999 |
I/I |
66,666 |
1,271,726 |
2.1 |
- |
|
Guerrero Ramiro |
Director |
|
2025-05-08 |
4 |
B |
$1.50 |
$30,000 |
D/D |
20,000 |
588,218 |
2.39 |
- |
|
Guerrero Ramiro |
Director |
|
2025-03-03 |
4 |
B |
$1.50 |
$50,000 |
D/D |
33,333 |
568,218 |
2.39 |
- |
|
Smith Stan |
Director |
|
2025-03-03 |
4 |
B |
$1.50 |
$37,500 |
I/I |
25,000 |
1,205,060 |
2.1 |
- |
|
Guerrero Ramiro |
Director |
|
2025-02-24 |
4 |
B |
$1.50 |
$110,000 |
D/D |
73,333 |
534,885 |
2.39 |
- |
|
Smith Stan |
Director |
|
2025-02-24 |
4 |
B |
$1.50 |
$75,000 |
I/I |
50,000 |
1,180,060 |
2.1 |
- |
|
Guerrero Ramiro |
Director |
|
2024-12-13 |
4 |
B |
$1.87 |
$99,998 |
D/D |
53,418 |
514,970 |
2.39 |
- |
|
Smith Stan |
Director |
|
2024-12-13 |
4 |
B |
$1.87 |
$46,800 |
I/I |
25,000 |
1,130,060 |
2.1 |
- |
|
Smith Stan |
Director |
|
2024-11-01 |
4 |
B |
$2.51 |
$251,000 |
I/I |
100,000 |
957,568 |
2.1 |
- |
|
Guerrero Ramiro |
Director |
|
2024-11-01 |
4 |
B |
$2.51 |
$222,220 |
D/D |
88,534 |
408,134 |
2.39 |
- |
|
Luput Cristian |
Director |
|
2024-11-01 |
4 |
B |
$2.51 |
$55,554 |
D/D |
22,133 |
389,483 |
2.39 |
- |
|
Chaouki Steven M |
Director |
|
2024-11-01 |
4 |
B |
$2.51 |
$55,554 |
D/D |
22,133 |
111,024 |
2.39 |
- |
|
Smith Stan |
Director |
|
2024-04-25 |
4 |
B |
$2.03 |
$299,409 |
I/I |
147,492 |
1,005,060 |
2.1 |
- |
|
Louie Ngar Yee |
Director |
|
2024-04-25 |
4 |
B |
$2.03 |
$39,920 |
D/D |
19,665 |
1,167,189 |
2.39 |
- |
|
Chaouki Steven M |
Director |
|
2024-03-14 |
4 |
B |
$1.17 |
$40,530 |
D/D |
34,641 |
88,891 |
2.39 |
- |
|
Luput Cristian |
Director |
|
2024-03-14 |
4 |
B |
$1.17 |
$81,060 |
D/D |
69,282 |
367,350 |
2.39 |
- |
|
Smith Stan |
Director |
|
2024-03-14 |
4 |
B |
$1.17 |
$200,000 |
I/I |
170,940 |
857,568 |
2.1 |
- |
|
Louie Ngar Yee |
Director |
|
2024-03-14 |
4 |
B |
$1.17 |
$200,000 |
D/D |
170,940 |
1,147,524 |
2.39 |
- |
|
Guerrero Ramiro |
Director |
|
2024-03-14 |
4 |
B |
$1.17 |
$8,106 |
D/D |
6,928 |
319,600 |
2.39 |
- |
|
Guerrero Ramiro |
Director |
|
2023-05-18 |
4 |
AB |
$2.47 |
$2,964 |
D/D |
1,200 |
312,672 |
|
- |
|
Luput Cristian |
Director |
|
2023-05-15 |
4 |
AB |
$2.63 |
$7,890 |
D/D |
3,000 |
298,068 |
|
- |
|
Vitoc Vlad |
Chief Executive Officer |
|
2023-04-28 |
4 |
AB |
$2.50 |
$10,000 |
D/D |
4,000 |
809,121 |
|
- |
|
Smith Stan |
Director |
|
2023-04-27 |
4 |
B |
$2.25 |
$299,925 |
I/I |
133,300 |
686,628 |
2.1 |
- |
|
Mcguire Joseph F |
Chief Financial Officer |
|
2023-04-27 |
4 |
B |
$2.25 |
$9,900 |
D/D |
4,400 |
9,400 |
2.74 |
- |
|
124 Records found
|
|
Page 1 of 5 |
|
|